SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-294013
Filing Date
2022-11-29
Accepted
2022-11-29 10:25:33
Documents
12
Period of Report
2022-11-29
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d426366d8k.htm   iXBRL 8-K 23594
  Complete submission text file 0001193125-22-294013.txt   147628

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vor-20221129.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE vor-20221129_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vor-20221129_pre.xml EX-101.PRE 11709
6 EXTRACTED XBRL INSTANCE DOCUMENT d426366d8k_htm.xml XML 3468
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 221429181
SIC: 2836 Biological Products, (No Diagnostic Substances)